MEDNAX Profile

45.60
USD 1.19  2.54%
0%
9%

Acquisition by Miller Frederick V Md of 9871 shares of MEDNAX subject to Rule 16b-3

MEDNAX insider trading alert for grant of common stock by Miller Frederick V Md, President Pediatrix Division, on September 23, 2018. This event was filed by Mednax Inc with SEC on 2010-06-03. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

MEDNAX Summary

MEDNAX (MD) is traded on BATS Exchange in USA. It is located in FLORIDA U.S.A and employs 11,825 people. MEDNAX was previously known as MEDNAX INC and was traded on BATS Exchange under the symbol PDX. MEDNAX is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with market capitalization of 4.38 B. MEDNAX is active under Healthcare sector as part of Medical Care industry. This company has 92.43 M outstanding shares of which 1.98 M shares are now sold short in the market by investors with about 2.41 days to cover all shorted shares. Mednax reports about 47.96 M in cash with 355.38 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Check MEDNAX Probability Of Bankruptcy

Ownership Allocation (%)

MEDNAX Target Price Odds Analysis

Odds Below 45.6HorizonTargetOdds Above 45.6
0.82%30 days 45.60 99.13%
Based on normal probability distribution, the odds of MEDNAX to move above current price in 30 days from now is close to 99% (This MEDNAX probability density function shows the probability of MEDNAX Stock to fall within a particular range of prices over 30 days) .

MEDNAX Top Holders

MEDNAX Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Price T Rowe Associates IncCommon Shares8.6 M370.5 M
Blackrock IncCommon Shares8.1 M351.7 M
View MEDNAX Diagnostics

MEDNAX Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

MEDNAX Key Fundamentals

MEDNAX Against Markets

MEDNAX Current Ratings

MEDNAX 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
46 
Equity ratings for MEDNAX are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida. MEDNAX operates under Medical Care classification in USA and traded on BATS Exchange. It employs 11825 people. more
Fama & French Healthcare
Healthcare
Fama & French Classification
MEDNAX SEC Filings
MEDNAX SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameMEDNAX
CEO, DirectorRoger MedelView All
Thematic Classification
Currently Active Investing Idea
Healthcare
  Healthcare
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Care
InstrumentUSA Stock View All
RegionNorth America
LocationFLORIDA U.S.A
Business Address1301 Concord Terrace
Foreign Associate  Mexico
ExchangeBATS Exchange
CIK Number0000893949
ISINUS58502B1061
CUSIP705324101
Prior SymbolPDX
SectorHealthcare
IndustryMedical Care
BenchmarkDOW
Websitewww.mednax.com
Phone954 384 0175
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

MEDNAX Directors

MEDNAX Corporate Directors

Enrique Sosa Independent Director
Waldemar Carlo Independent Director
Paul Gabos Independent Director
Please see also Stocks Correlation. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Search macroaxis.com